June 22, 2020 / 12:55 PM / 21 days ago

BRIEF-Corbus Pharma Reports Last Subject Visit In Phase 2B Study Of Lenabasum For Treatment Of Cystic Fibrosis

June 22 (Reuters) - Corbus Pharmaceuticals Holdings Inc :

* CORBUS PHARMACEUTICALS REPORTS LAST SUBJECT VISIT IN PHASE 2B STUDY OF LENABASUM FOR TREATMENT OF CYSTIC FIBROSIS

* CORBUS PHARMACEUTICALS HOLDINGS INC - TOPLINE DATA FOR LENABASUM ON SCHEDULE FOR Q3 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below